Juli

SmartSoda® Expands Distribution Reach Through Partnership with Consolidated Services Group, LLC

Retrieved on: 
Friday, August 11, 2023
Food Tech, Retail, IOT (Internet of Things), Technology, Other Retail, Food, Beverage, Partnership, Juli, Internet of things, Multimedia, Foodservice, Tumbler, Tea, Coffee, ROI, Bottled water

View the full release here: https://www.businesswire.com/news/home/20230811046368/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230811046368/en/
    The JuLi is unlike any water cooler you've ever experienced.
  • (Photo: Business Wire)
    “Our partnership with Consolidated Services Group allows us to immediately grow our sales and servicing network while providing Consolidated Services Group with a healthy hydration solution to offer their customers through the SmartSoda all-in-one JuLi™, dispensing system,” explained SmartSoda CEO, Lior Shafir.
  • The JuLi delivers twenty-nine flavors, sparkling or still alkaline water and offers cold brew coffee, iced tea and lemonade.
  • I could not be more excited for our team to take this great company into the market,” said Salterio.

DIGITAL HEALTH PLATFORM IMPROVES ASTHMA AND DEPRESSION OUTCOMES IN TWO CLINICAL TRIALS

Retrieved on: 
Thursday, August 10, 2023
ACT, University College London, UCL, Asthma, Depression, Isabella Tree, University, RCT, Medicine, Harvard Medical School, Doctor of Philosophy, MCID, Juli, Literature, Odds ratio, Patient, Master of Science, Psychiatry, Digital, Pharmaceutical industry, Dermatology, MD

BOSTON, Aug. 10, 2023 /PRNewswire/ -- In two large randomized controlled trials (RCTs) conducted with patients diagnosed with two different chronic conditions, the digital health app juli demonstrated efficacy by improving outcomes in people with either asthma or depression compared to participants using an active control app, the company reported today.

Key Points: 
  • They were conducted in collaboration with University College London (UCL), ranked among the top 10 universities for life sciences and medicine globally.
  • juli joins a small group of digital health apps to have completed RCTs, considered the gold standard for the evaluation of medical interventions.
  • In both studies, the primary endpoint of statistically significant improvements compared to control was achieved, with p=0.020 in the asthma RCT and p=0.045 in the depression RCT.
  • "The fact that they've now demonstrated efficacy across two conditions as diverse as asthma and depression validates their approach and is very encouraging."

SmartSoda And Compass Group North America Partner To Deliver A Breakthrough In Workplace Wellness And Hydration

Retrieved on: 
Wednesday, April 12, 2023
Food Tech, Retail, IOT (Internet of Things), Technology, Office Products, Food, Beverage, Tea, Taste, Coffee, Maintenance, Partnership, Multimedia, Juli, Tumbler, Internet of things, Bottled water, Compass

View the full release here: https://www.businesswire.com/news/home/20230411005986/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230411005986/en/
    SmartSoda and Compass, a breakthrough in the break room with the JuLi.
  • Delivering sparkling water to coffee to iced tea, lemonade, and everything in between,” explained SmartSoda CEO, Lior Shafir.
  • The JuLi uses recyclable bibs to deliver multiple flavors and varieties, ultimately reducing the need for cans and bottles.
  • The Compass partnership also provides real-time customer service and a national network of service technicians.

Digital Health Platform Reduces Bipolar Disorder Symptoms in More Than Half of Users

Retrieved on: 
Wednesday, September 7, 2022
Chronic pain, AUC, UCL, Juli, CEO, University College London, Hospital, Receiver operating characteristic, Caregiver, Research, Comorbidity, Migraine, Air pollution, Altmann, Bipolar disorder, Doctor of Philosophy, Time, Canadian International Council, Associate, Behavior, Psychiatry, Mania, Manic, Randomized controlled trial, Suicide, Asthma, Grammatical mood, ASMR, ASRM, Depression, Hypomania, Patient, Prevalence, Hypertension, Population, Weather, Patient Health Questionnaire, Sleep hygiene, Health, Environment, Lithium, Medical device, Poultry, Pharmaceutical industry, Risk management, ROC, MD

BOSTON, Sept. 7, 2022 /PRNewswire/ -- juli, the AI-powered chronic condition platform, released the results of a first-of-its-kind analysis demonstrating a 55 percent reduction in the number of people with bipolar disorder who experience symptoms of mania after only eight weeks using the juli app.

Key Points: 
  • Bipolar disorder is a lifelong, recurrent, episodic illness with high rates of hospitalization, suicide and comorbidity.
  • As of July 2022, 2,987 people with bipolar disorder had downloaded the juli app.
  • Of those, 77% (2,300) confirmed that they had been diagnosed with bipolar disorder by a psychiatrist.
  • More than half indicated they had experienced bipolar disorder for more than five years and 65 percent were seeing a physician regularly.

juli Welcomes Michael Seggev as Senior Vice President/Commercial

Retrieved on: 
Wednesday, May 25, 2022
Senior, Chronic kidney disease, Program, SoftBank Group, Software, Office of Inspector General, U.S. Department of Health and Human Services, AI, Asthma, Leadership, Migraine, Patient, COPD, Juli, Health, Human services, COVID-19, Merck, Bipolar disorder, Depression, Artificial intelligence, Caregiver, Pedigree, Heart, Conditional sentence, Digital health, Biomarker, Chronic pain, Chronic obstructive pulmonary disease, Machine learning, HIV, CHF, Pharmaceutical industry, Health insurance, Medical device, Teva

BOSTON, May 25, 2022 /PRNewswire/ -- juli , the AI-powered digital health platform that delights and engages consumers to power their own health while offering their healthcare providers insights from sub-episodic health data, today announced the appointment of Michael Seggev as Senior Vice President/Commercial.

Key Points: 
  • BOSTON, May 25, 2022 /PRNewswire/ -- juli , the AI-powered digital health platform that delights and engages consumers to power their own health while offering their healthcare providers insights from sub-episodic health data, today announced the appointment of Michael Seggev as Senior Vice President/Commercial.
  • Seggev will be responsible for leading U.S. and global commercialization of juli and will report directly to CEO Bettina Hein.
  • Seggev brings over 25 years of commercialization experience in healthcare, including B2B go-to-market planning and launch leadership at two disruptive digital health startups.
  • "I look forward to working with Michael to amplify our team's ability to drive the value of juli with these key customers."

Precision BioSciences Appoints Juli Blanche as Chief People Officer

Retrieved on: 
Monday, May 23, 2022
Oncology, Health, Genetics, Research, Science, Biotechnology, People, Marist College, Acqui-hiring, Communication, Company, BMS, Genome, Juli, Bristol Myers Squibb, Nasdaq, HR, Leadership, Multimedia, Infection, Gene editing, Â, Workforce, Inclusion, Partnership, Life, List, Global Commercial Credit, Operation, Perseverance, SVP, CAR, Precision, Business, Morgan Stanley, Management, Celgene

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that Juli Blanche has been appointed Chief People Officer and a member of the senior leadership team at Precision BioSciences.

Key Points: 
  • Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that Juli Blanche has been appointed Chief People Officer and a member of the senior leadership team at Precision BioSciences.
  • View the full release here: https://www.businesswire.com/news/home/20220523005555/en/
    Juli Blanche joins gene editing company Precision BioSciences as newly appointed Chief People Officer.
  • (Photo: Business Wire)
    We are very excited to welcome Juli to Precision BioSciences and our senior leadership team, said Michael Amoroso, Chief Executive Officer of Precision BioSciences.
  • Prior to joining Precision BioSciences, Juli was with BMS where she held several roles, each with increasing global responsibility.

juli secures $3.8 million for AI-powered platform to help manage chronic conditions

Retrieved on: 
Thursday, March 3, 2022
Hive, Famine, Intelligence, Leadership, Patient, Human services, Accelerator, U.S. Department of Defense Strategy for Operating in Cyberspace, Participation, Asthma, Om, TourRadar, College, Migraine, VIVE, Bipolar disorder, College of Healthcare Information Management Executives, Juli, SoftBank Group, Office of Inspector General, U.S. Department of Health and Human Services, Growth, Vive, HR, Poverty, Chronic pain, Mental health, Hein, Science and technology in Asia, CEO, CHIME, Caregiver, Program, General partnership, Education, AI, Technology, Depression, Health, Pressure, VC, Cryptocurrency, Health insurance, Medical device, Renewable energy, Klarna, Norrsken Foundation

BOSTON, March 3, 2022 /PRNewswire/ -- juli , the AI-powered digital health platform empowering patients and their care teams to manage complex chronic conditions, announced it has secured $3.8 million in a seed funding round.

Key Points: 
  • BOSTON, March 3, 2022 /PRNewswire/ -- juli , the AI-powered digital health platform empowering patients and their care teams to manage complex chronic conditions, announced it has secured $3.8 million in a seed funding round.
  • "juli is helping patients, providers and employers identify behavioral triggers that worsen or improve the most hard-to-treat and complex chronic conditions, including asthma, migraines, depression and bipolar disorder," said Bettina Hein, CEO and co-founder of Boston-based juli.
  • Since launching a year ago, approximately 15,000 patients have used the juli app to track data for chronic, debilitating conditions.
  • juli is a management platform that empowers patients and their care teams to manage complex chronic conditions.